China Adds 13-Year-Old Girls to HPV Vaccination Target

This move signals a deliberate public-health prioritization of pre-adolescent vaccination at the population level, likely reflecting long-term cost-benefit modeling rather than immediate outbreak response. For markets, it underscores expanded government-backed vaccine procurement in a large demographic, which could influence demand forecasts for HPV vaccine manufacturers and distributors. The open question is how quickly implementation scales across regions and whether similar age-targeting policies emerge in other emerging markets, as that would set a precedent for national immunization strategy.